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M), protein kinase G adenovirus (Ad-cGKI␤; 10 10 plaqueforming units/ml), atrial natriuretic peptide (ANP), and Ctype natriuretic peptide (CNP) inhibited the promoter activity of cyclin E to 49, 57, 77, and 78%, respectively. On the other hand, the promoter activities of cyclin D1 and cyclin A were not changed significantly. In Western blot analysis, 8-BrcGMP, Ad-cGKI␤, ANP, and CNP also inhibited cyclin E protein expression dose and time dependently. The p44/p42 mitogen-activated protein kinase (MAPK) kinase 1-p44/p42 MAPK had no effect on cyclin E promoter activities, and the cGMP-protein kinase G pathway did not change MAPK activity. In conclusion, our findings suggest that the reduction of the cyclin E promoter activity that downregulates G1/S transition plays a dominant role in the cGMP-and protein kinase G-induced inhibition of mesangial cell proliferation. mitogen-activated protein kinase; cyclin A; cyclin D1; atrial natriuretic peptide; C-type natriuretic peptide MESANGIAL CELL PROLIFERATION is an essential component of glomerulonephritis. In recent studies, many cytokines have been shown to either promote or suppress the cell cycle of mesangial cells. Because the interactions between these factors and regulational mechanisms of the mesangial cell cycle are not well known, learning more about them would be of great help in developing a curative treatment for mesangial proliferative glomerulonephritis.
Atrial natriuretic peptide (ANP) and C-type natriuretic peptide (CNP) play an important role in many physiological functions that change the hemodynamics, such as vasorelaxant activity in vascular smooth muscle cells (VSMC) and promotion of urinary excretion of sodium and water by the kidney (3, 32) . These cytokines also exhibit a growth inhibitory response in renal mesangial cells, VSMC, and endothelial cells that is mediated by the intracellular second messenger cGMP via an involvement of the cGMP-dependent protein kinase, protein kinase G (4, 9, 10, 24) . Former investigations suggested that these cytokines and the cGMP-protein kinase G pathway have important roles in mesangial cell proliferation (6) . For example, in in vitro studies, ANP and CNP inhibited mesangial cell proliferation (1, 2, 18) , and in an in vivo study, continuous infusion of CNP prevented the proliferation of mesangial cells in a rat mesangioproliferative anti-Thy1.1 model (5) .
However, inhibitory signaling pathways of cGMPprotein kinase G are not well known. In recent studies, several different pathways have been proposed, for example, the inhibitory pathways via upregulation of the Gax-p21 cip1 (11, 27) and transforming growth factor (TGF)-␤ (25, 35) , reduction of cyclin A (14) , and suppression of the mitogen-activated protein kinase (MAPK) cascade (7, 15) .
In the present study, to determine the stage of cell cycle progression that is suppressed by protein kinase G in mesangial cells, we investigated the effects of adenovirus-mediated overexpression of protein kinase G on G 1 cyclin promoter activities. We found that protein kinase G overexpression decreased cyclin E expression transcriptionally and inhibited the cell cycle at the G 1 /S transition in mesangial cells. We conclude that the reduction of cyclin E promoter activity plays a dominant role in cGMP-and protein kinase G-induced inhibition.
METHODS
Mesangial cell culture. Mesangial cell strains from male Sprague-Dawley rats were isolated and characterized as previously reported (23) . Cells were cultured in RPMI 1640 medium containing 20% FBS, 100 U/ml penicillin, 100 g/ml streptomycin, 5 g/ml insulin, 5 g/ml transferrin, and 5 ng/ml selenite at 37°C in a 5% CO 2 incubator. The cells were seeded in 10-cm dishes for all experiments except the experiment on [ 3 H]thymidine incorporation in which 24-well dishes were used. When the cells reached 80% confluence, they were either treated with an indicated dose of 8-bromocGMP (8-BrcGMP), 8-bromo-cAMP (8-BrcAMP) in 20% FCS medium for 48 h, or infected with either protein kinase G adenovirus (Ad-cGKI␤) or Ad-LacZ in 20% FCS medium for 48 h. For the experiment in Fig. 5 , when the cells reached 80% confluence they were incubated in 0.5% FCS starved medium for 48 h and then changed to the 0.5% FCS medium containing 25 ng/ml platelet-derived growth factor (PDGF)-BB with 8-BrcGMP or infected with Ad-cGK␤I for 48 h. In our preliminary experiments, we confirmed that the magnitude of PDGF-BB stimulation in the mesangial cell proliferation at 80% confluency was not different from that at 60% confluency.
Antibodies. Antibodies against anti-mouse-cyclin D1, antirabbit-cyclin A, and anti-rabbit-cyclin E were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Antibodies against anti-p44/p42 MAPK, anti-phospho-p44/p42 MAPK, and human retinoblastoma (Rb) protein were purchased from New England Biolabs (Beverly, MA). Anti-myc antibody was purchased from Invitrogen (Carlsbad, CA). Antibody against human cGKI␤ (protein kinase G type I␤) was described previously (20) .
Construction of adenovirus. Ad-cGKI␤, a replication-defective, recombinant adenovirus driven by cytomegalovirus promoter, was described previously (34) . The recombinant adenovirus Ad-LacZ was provided by Dr. I. Saito (17) . Each adenovirus preparation was titrated by plaque assay on 293 cells.
Reporter constructs and plasmids. The cyclin D1 reporter construct used for luciferase assays contained human cyclin D1 promoter from residues Ϫ944 to ϩ139 cloned upstream of the luciferase gene (generous gift of Dr. M. Eilers; see Ref. 28) . The cyclin A reporter construct contained human cyclin A promoter from residues Ϫ924 to ϩ245 (generous gift of Dr. J. Sobczak-Thepot; see Ref. 8) , and the cyclin E reporter construct contained human cyclin E promoter from residues Ϫ1,195 to ϩ79 cloned upstream of the luciferase gene (generous gift of Dr. K. Ohtani; see Ref. 22) . Cyclin E plasmid construct was provided by Dr. S. Coats (12) . Wild-type p44/ p42 MAPK kinase 1 (MKK1), dominant-active MKK1 S222E, and dominant-negative MKK1 S222A were generous gifts of Dr. E. G. Krebs (27) . 3 H]thymidine (Amersham) was added to the medium. The cells were washed three times in 4°C PBS, cold 10% TCA was added to precipitate protein and DNA, and the mixture was redissolved in 0.5 M NaOH. Aquasol-2 scintillation cocktails (NEN Research Products, Boston, MA) were counted in a scintillation counter. The measurement was made at 48 h, the point at which we observed maximum inhibition of cyclin E protein expression, as described later in RESULTS. In a preliminary experiment, we also observed maximum inhibition of [ Cell cycle analysis by flow cytometry. Mesangial cells were cultured in 10-cm dishes. The cells were incubated in 20% FCS medium with indicated doses of 8-BrcGMP for 48 h. The samples were washed two times with PBS and then resuspended in 70% ethanol for 1 h at 4°C. Fixed and permeated cells were collected by centrifugation, washed with PBS, treated with RNase, and stained with propidium iodide. The numbers of cells in the G 1, S, and G2/M phases were analyzed by flow cytometry using a fluorescence-activated cell sorter (FACS) calibur (Becton-Dickinson, San Jose, CA) as described previously (31, 33) .
Cyclin E-dependent kinase assay. Immune complex kinase assay was performed using essentially the same methods as previously described by Terada et al. (31) . Mesangial cells were treated with 8-BrcGMP or infected with Ad-cGKI␤ for 48 h. The cell lysates were clarified by centrifugation at 10,000 g for 5 min. After incubation of the supernatants for 2 h at 4°C with 10 l of anti-cyclin E antibody and then for 1 h with 30 l of protein G-agarose (Boehringer Mannheim, Mannheim, Germany), immune complexes were recovered by centrifugation. Immunoprecipitated proteins were suspended in 30 l of kinase buffer [50 mM HEPES (pH 7.5), 10 mM MgCl 2, and 1 mM dithiothreitol] containing 0.2 g of histone H1 (Boehringer Mannheim) and 2.5 mM EGTA, 10 mM ␤-glycerophosphate, 1 mM NaF, 20 M ATP, and 10 Ci of [␥-
32 P]ATP (NEN). After incubation for 30 min at 30°C with occasional mixing, the samples were boiled in polyacrylamide gel sample buffer containing SDS and separated by electrophoresis. Phosphorylated proteins were analyzed by a BAS station (Fuji, Tokyo, Japan).
Transient transfection and luciferase assay. Mesangial cells were transfected by the electroporation method with 4 g of ␤-galactosidase construct and 20 g of cyclins E, D1, or A promoter construct. After transfection, the cells were cultured in medium containing 20% FCS for 12 h and then either changed to a 20% FCS medium containing an indicated dose of 8-BrcGMP or infected with Ad-cGKI␤ or AdLacZ in a 20% FCS medium for 48 h as a control. Luciferase and ␤-galactosidase activities were measured according to the protocols of the manufacturer (Promega, Madison, WI). Luciferase enzyme units were normalized to ␤-galactosidase. Our previous report demonstrated that the transfection efficiency of our electroporation method in mesangial cells was around 30% (21) .
Generation of cyclin E-expressing clones. Twenty micrograms of cyclin E plasmid containing the neo resistant gene and myc gene were transfected into mesangial cells by electroporation. The cells were cultured in medium containing 20% FCS and G418 (200 g/ml; GIBCO-BRL, Grand Island, NY) to expand the G418-resistant clones. The exogenous cyclin E expression of each clone was examined by Western blot analysis using anti-myc antibody (data not shown). The selected clones found to express exogenous cyclin E protein expression were maintained in medium containing G418 to preserve their indelibility and used for the experiment (26) .
Western blot analysis. Whole cell lysates were extracted from the cultured mesangial cells and lysed in the buffer (50 mM HEPES, (pH 7.5), 150 mM NaCl, 1.5 mM MgCl2, 1 mM EGTA, 10% glycerol, 1% Triton X-100, 1 g/ml aprotinin, 1 g/ml leupeptin, 1 mM phenylmethylsulfonyl fluoride, and 0.1 mM sodium orthovanadate) at 4°C. After incubation for 5 min, lysates were centrifuged at 4°C for 15 min at 10,000 g. The soluble lysates were mixed 1:4 with 5ϫ Laemmli buffer and heated for 5 min at 95°C. Forty micrograms of protein extracts were subjected to Western blotting with anti-cyclin E, anti-cyclin D1, anti-cyclin A, anti-Rb, anti-p44/p42 MAPK, anti-phospho-p44/p42 MAPK, or anti-protein kinase G. Pro-teins were separated in SDS-10% polyacrylamide gels and transferred to an Immobilon-P membrane (Daiichikagaku, Tokyo, Japan). Blots were incubated in 5% nonfat dry milk (in 1ϫ PBS, 0.1% Tween 20) for 1 h at room temperature and then incubated with the indicated antibodies (1:1,000 dilution in 5% nonfat dry milk, 0.1% Tween 20 in 1ϫ PBS) for 2 h. After three washes in 0.1% Tween 20 in 1ϫ PBS (15 min, 5 min, 5 min), blots were incubated with horseradish peroxidase-conjugated secondary antibodies (1:2,500 dilution) for 1 h. After three more washes using the method described before, membranes were visualized by the Amersham enhanced chemiluminescence system (Amersham, Arlington Heights, IL).
Statistics. All values were expressed as means Ϯ SE. The differences were tested using ANOVA. P Ͻ 0.05 was considered significant.
RESULTS

cGMP and overexpression of protein kinase G decreased [ 3 H]thymidine incorporation and the cell numbers of S and G 2 /M phases in cultured mesangial cells.
We first examined the effects of cGMP and protein kinase G overexpression on mesangial cell proliferation by measuring Figure  1A shows a dose-dependent reduction of [ 3 H]thymidine uptake by 8-BrcGMP and Ad-cGKI␤ transfection compared with the control. In the Ad-cGKI␤ experiments, we used Ad-LacZ-infected cells as a control. In a previous study, we showed that the transfection efficiency of adenovirus (Ad-LacZ) was nearly 99% in mesangial cells (33) . Overexpression of protein kinase G protein was confirmed by Western blotting (see Fig. 3A ). These data indicate that cGMP and protein kinase G inhibit mesangial cell proliferation. To verify the inhibition of cell proliferation by cGMP, we performed cell cycle analysis by FACS. Mesangial cells were cultured in 10-cm dishes and incubated in 20% FCS medium with 8-BrcGMP for 48 h (Fig. 1B) . 8-BrcGMP reduced the cell numbers of S and G 2 /M phases in a dose-dependent manner. These data suggest that 8-BrcGMP halts the cell cycle at the G 1 phase and prevents its progression to the S phase.
cGMP and protein kinase G reduced the phosphorylation of Rb protein. To examine the inhibitory mechanism of cGMP and protein kinase G in the G 1 /S transition, we examined the phosphorylation state of Rb protein by Western blot analysis using an antibody specific to Rb proteins. Cells were treated with 8-BrcGMP (10 Ϫ3 M) or infected with Ad-cGKI␤ (10 10 pfu/ml) for 48 h, and whole cell lysates were used for analysis. In Fig. 2 , two parallel bands were observed, and the top band represented phosphorylated Rb protein. 8-BrcGMP and Ad-cGKI␤ decreased the phosphorylation of Rb proteins. cGMP and protein kinase G decreased the protein expression of cyclin E but not of other cyclins. We next examined the protein expressions of G 1 /S phase cyclins (cyclin E, cyclin D1, and cyclin A) by Western blot analysis. 8-BrcGMP and Ad-cGKI␤ both significantly decreased the cyclin E protein level in a dose-dependent manner (Fig. 3A) . We also confirmed that there were no differences in cyclin E protein expressions between control cells and Ad-LacZ-infected cells. Figure 3B shows the time course of the inhibitory effect of 8-BrcGMP on cyclin E protein expression, where the maximum effect was observed at 48 h. In contrast, neither cGMP nor protein kinase G affected cyclin D1 and A expressions. Furthermore, we examined protein kinase G protein expression to confirm the successful gene transfer of protein kinase G to mesangial cells (Fig. 3A) .
cGMP induced dose-dependent decreases in the promoter activity of cyclin E but not of other cyclins.
To investigate the role of the cGMP-protein kinase G signaling pathway in the transcriptional regulation of cyclin E, cyclin D1, and cyclin A, we measured promoter activity using plasmids containing cyclin E, D1, and A promoter regions and luciferase reporter genes. Mesangial cells transfected with cyclin E promoter construct reduced the activity by 8-BrcGMP dose dependently. 8-BrcGMP (10 Ϫ4 M) reduced cyclin E promoter activity to 55% and 10 Ϫ3 M 8-BrcGMP reduced the activity to 49% compared with the control (Fig. 4) . The cyclin E promoter activity of Ad-cGKI␤-infected cells was reduced to 57% compared with that of the Ad-LacZ-infected cells (control). In contrast, the promoter activities of the cells transfected with cyclin D1 and A promoter constructs did not show any statistically significant changes by 8-BrcGMP and Ad-cGKI␤. These data suggest that the reduction of the cyclin E promoter activity that downregulates the G 1 /S transition is a dominant factor for the cGMP-and protein kinase G-induced inhibition of mesangial cell proliferation.
cGMP and protein kinase G inhibited the mesangial cell proliferation induced by PDGF-BB and decreased cyclin E transcription.
We next examined if the inhibitory effect of the cGMP-protein kinase G pathway was altered by different proliferative stimuli. Before addition of PDGF-BB, the cell quiescence was achieved by incubation for 48 h in RPMI 1640 with 0.5% FCS. The cell were then exposed to the 0.5% FCS medium containing PDGF-BB (25 ng/ml) for 48 h. [ 3 H]thymidine uptake, cyclin E promoter activity, and cyclin E protein expression were examined by the same processes as described previously. cGMP and protein kinase G decreased the PDGF-BB-induced [ 3 H]thymidine uptake, cyclin E promoter activities, and cyclin E protein expression of the mesangial cells (Fig. 5). cGMP and protein kinase G decreased cyclin E-dependent kinase activity. To further determine the involvement of cyclin E in the inhibitory effect of cGMPprotein kinase G on mesangial cell proliferation, we measured cyclin E-dependent kinase activity using histone H1 as substrate. Figure 6 shows that 8-BrcGMP (10 Ϫ3 M) and the overexpression of protein kinase G inhibited the cyclin E-dependent kinase activities. These data were consistent with the reduction of Rb protein phosphorylation by the cGMP-protein kinase G system.
ANP and CNP decreased [ 3 H]thymidine incorporation, cyclin E promoter activity, and the cyclin E protein
level. ANP and CNP were reported to increase cGMP in mesangial cells (1, 2). Thus we next examined whether these peptide hormones also inhibit the mesangial cell proliferation and change cyclin E expression. The cells were treated with indicated doses of ANP or CNP for 48 h. (Fig.  7A) . Mesangial cells were transiently transfected with cyclin E promoter plasmid, treated with ANP or CNP for 48 h, and assayed for luciferase activities. Both ANP and CNP reduced cyclin E promoter activities dose dependently (Fig. 7B) . Next, the cells were treated with ANP and CNP for 48 h, and then the whole cell lysates from these cells were analyzed by Western blotting. Cyclin E protein levels were decreased by ANP and CNP in a dose-dependent manner (Fig. 7C ). ANP and CNP inhibited cyclin E at both transcriptional and protein levels, and these data are compatible with the results from former experiments.
cAMP did not inhibit mesangial cell proliferation or decrease cyclin E protein expression. Mesangial cells were treated with indicated doses of 8-BrcAMP for 48 h. [
3 H]thymidine was pulsed for the last 4 h, and [ 3 H]thymidine uptake was measured. 8-BrcAMP did not have an anti-mitogenic effect on the mesangial cells (Fig. 8A) . We also examined the effect of 8-BrcAMP on cyclin E protein expression by Western blot analysis. 8-BrcAMP did not decrease the cyclin E protein levels (Fig. 8B) . Overexpression of cyclin E reversed the anti-mitogenic effect of cGMP. To confirm that the suppression of cyclin E transcription is essential to the anti-mitogenic effect of cGMP, we examined whether the overexpression of cyclin E overcame the inhibitory effect of cGMP by analyzing the cell cycle by flow cytometry. Rat mesangial cells were transfected with 20 g of cyclin E plasmid and cultured in medium containing G418. G418-resistant clones that expressed exogenous cyclin E were selected for the experiment. Original mesangial cells and mesangial cells expressing exogenous cyclin E were cultured at 80% confluence with or without 8-BrcGMP for 48 h and examined by flow cytometry for cell cycle analysis (Fig. 9A) . In original mesangial cells, 8-BrcGMP reduced the percentage of S and G 2 /M phases to 10 and 33%, respectively. However, in the mesangial cells that expressed exogenous cyclin E, the reduction of the percentage of S and G 2 /M phases was attenuated and recovered to the control level (Fig. 9B) . The data suggested that cyclin E could overcome the anti-mitogenic effect of cGMP and that the inhibitory effect of cGMP worked through cyclin E.
The MKK1-p44/p42 MAPK pathway did not significantly change cyclin E promoter activity. To examine the involvement of the MKK1-p44/p42 MAPK pathway in cyclin E promoter activity, rat mesangial cells were cotransfected with cyclin E promoter plasmid construct and either wild-type MKK1, dominant-active MKK1 S222E, dominant-negative MKK1 S222A, or dominantactive MKK1 S222E with PD-98059 (10 Ϫ6 M). After 48 h of incubation, the luciferase activities were assayed. Cyclin E promoter activities were not changed significantly by transfection with either constitutive active or negative MKK1 constructs (Fig. 10A) . These results suggested that the MKK1-p44/p42 MAPK pathway did not significantly change cyclin E promoter activity in our experimental condition. To confirm the effectiveness of the dominant-negative mutants and PD-98059 used in this experiment, we examined the protein expressions of p44/p42 MAPK and phosphop44/p42 MAPK in the mesangial cells transfected with either wild-type MKK1, dominant-active MKK1 S222E, dominant-negative MKK1 S222A, or dominantactive MKK1 S222E with PD-98059 (10 Ϫ6 M). The transfections of dominant-negative MKK1 S222A and dominant-active MKK1 S222E with PD-98059 (10 Ϫ6 M) to the mesangial cells reduced the phosphorylation of p44/p42 MAPK without changing the total amount of p44/p42 MAPK (Fig. 10B) . The results confirmed the effectiveness of the dominant-negative mutants and PD-98059 used in this study.
DISCUSSION
In this study, we show that protein kinase G overexpression by adenovirus decreases cyclin E transcriptionally and inhibits the cell cycle at the G 1 /S transition in mesangial cells. We observed a reduction of cyclin E promoter activity by protein kinase G and found that the mechanisms of the antiproliferative effect of cGMP-protein kinase G were associated with a decrease in the transcriptional level of cyclin E expression.
These results were also confirmed by other experiments. First, cGMP and protein kinase G overexpression decreased [ 3 H]thymidine incorporation, delayed the progression from the G 0 /G 1 phase to the S and G 2 /M phases, and reduced the phosphorylation of Rb Fig. 9 . Overexpression of cyclin E reversed the anti-mitogenic effect of cGMP. Rat mesangial cells were transfected with 20 g of cyclin E plasmid and cultured in medium containing G418. Drug-resistant clones that expressed exogenous cyclin E were selected and expanded. Original mesangial cells and mesangial cells expressing exogenous cyclin E were cultured at 80% confluence with or without 8-BrcGMP for 48 h. A: flow cytometry was performed for cell cycle analysis. B: percentages of cells in the S and G2/M phase were analyzed. Each bar represents the mean Ϯ SE; n ϭ 4. NS, not significant. *P Ͻ 0.05 by ANOVA. Fig. 10 . Involvement of the p44/p42 mitogenactivated protein kinase (MAPK) kinase (MKK1)-p44/p42 MAPK pathway in the promoter activity of cyclin E. A: mesangial cells were cotransfected with cyclin E reporter plasmid construct and either wild-type MKK1, dominant-active MKK1 S222E, dominant-negative MKK1 S222A, or dominant-active MKK1 S222E with PD-98059 (10 Ϫ6 M). After 48 h, promoter activities were assayed as described in METHODS. Each bar represents the mean Ϯ SE; n ϭ 4. B: mesangial cells were transfected with either wild-type MKK1, dominant-active MKK1 S222E, dominant-negative MKK1 S222A, or dominant-active MKK1 S222E with PD-98059 (10 Ϫ6 M). Protein expressions of p44/p42 MAPK and phospho-p44/p42 MAPK were analyzed by Western blot.
proteins. This evidence suggested that G 1 cyclins are important factors for inhibition (19) . Second, in Western blot analysis, cyclin E was the only G 1 cyclin to be suppressed by cGMP and protein kinase G. Third, cGMP and overexpression of protein kinase G reduced the cyclin E-dependent kinase activity, thereby inhibiting the progression of the cell cycle at the G 1 phase. Fourth, overexpression of cyclin E overcame the antimitogenic effect of cGMP, indicating that the inhibitory effect of cGMP worked through cyclin E. Finally, ANP and CNP, the upstream signals of cGMP-protein kinase G, also transcriptionally inhibited cyclin E gene expression. All of these observations were compatible with the inhibition by the cGMP-protein kinase G pathway observed earlier.
As far as we know, this is the first report demonstrating that transcriptional inhibition of the cyclin E gene is involved in cell cycle inhibition by cGMP and protein kinase G. Compared with former investigations, this study took a more direct approach to the mechanisms of inhibition in two ways. First, we directly examined the promoter activities of G 1 cyclins and elucidated that the inhibition occurred at a transcriptional level. Second, we directly used the adenovirus-mediated overexpression of protein kinase G. This method skirted the problem of the involvement of other signal transductions via processes not involving protein kinase G, such as cross-activation via cAMP. Using this method, we also sidestepped the potential risk of inhibition by the toxic effect of the cGMP analog (2). We also used 8-BrcAMP instead of 8-BrcGMP in the investigations of thymidine incorporation, cyclin E promoter activity, and cyclin E protein expression to examine the cross-activation between these two messengers; however, in our experiments, 8-BrcAMP did not change either thymidine uptake, the promoter activities, or the protein expression.
According to former investigations, several antiproliferative pathways were reported downstream of protein kinase G, for example, pathways via cyclin A (14), Gax-p21 cip1 (27) , c-fos (13, 16) , and TGF-␤ (25, 35) . This diversity may have been due to the difference of cell type or experimental conditions. Several studies demonstrated that cGMP suppressed the cell cycle via reduction of MAPK activity in VSMC (36) and rat mesangial cells (15, 30) . To clarify this, we examined cyclin E promoter activity after transfecting dominantactive and dominant-negative forms of MKK1 plasmid constructs. From the results under our experimental condition, cyclin E promoter activity was not affected by MAPK and its inhibitor PD-98059 (Fig. 10) ; however, it will be necessary to examine several experimental conditions to confirm the effects of the MAPK pathway on the cGMP signaling system. Further studies may be necessary to clarify the complex signaling pathways involved in the regulation of the mesangial cell cycle.
In summary, we demonstrated that the inhibition of cyclin E transcription is the main factor of suppression of the cell cycle by cGMP-protein kinase G in mesangial cells. Determination of the functional roles of the cGMP-protein kinase G pathway is important for understanding the mechanisms of mesangial cell proliferation. Our findings may permit the development of new strategies to understand the mechanism of mesangial proliferative glomerulonephritis and ways to inhibit it.
